Why patient advocacy matters in health care crises.

The Spaces features attorney Warner Mendenhall and nurse-advocate Priscilla Romans discussing how Graith Care’s virtual patient advocacy supports complex cases, using Warner’s recent stage IV cancer journey as a case study. Warner describes a hybrid approach—standard chemotherapy via University Hospitals plus adjunctive nutraceuticals—where Graith Care fast-tracked MRIs/CTs, coordinated specialist input (including oncologist Dr. Orlando Silva), structured supplement timing and dosing, and translated labs and insurance details, emphasizing constant monitoring for organ safety and individualized protocols. Priscilla outlines Graith Care’s 30+ advocate team (oncology, pharmacy, insurance, pediatric/neonatal, senior care) operating internationally since 2020 to cut delays, blend traditional and alternative options, and provide practical access that call centers and overstretched clinics often lack. She highlights their 501(c)(3) Grateful Giving, which funds donated advocacy time, with examples like arranging a bloodless infant heart surgery and case-matching clients to the right advocate. Broader themes include medical freedom, pediatric vaccine decision-making, court and CPS pressures, and cross‑professional collaboration. A listener, Shelly, adds a cautionary perspective about protocols and urges objective testing, noting the costs and limits of overseas options. The hour closes with thanks, next-step media plans, and calls for support.

Session recap: Integrative patient advocacy for serious illness (Warner Mendenhall & Priscilla Romans)

Participants and roles

• Warner Mendenhall (host; attorney with the Freedom Council): Recently and publicly diagnosed (early December) with stage 4C metastatic cancer; undergoing hospital-based chemotherapy plus adjunct nutraceuticals; speaking as a current client of the advocacy service discussed.
• Priscilla Romans (guest; founder/lead of the advocacy service repeatedly referred to as Great/Grace/Graith Care in the call; former ICU nurse and healthcare operations leader): Describes the service’s model, team, nonprofit arm, and integrative approach.
• Dr. Orlando Silva (mentioned; medical oncologist, ~36+ years’ oncology experience; specialty advocate on the team): Provides oncology guidance, dosing/scheduling for integrative protocols, and case/legal reviews.
• Shelly (audience): Vaccine-injured and on cancer protocols; shares cautionary, first-hand perspective on protocols, testing, costs, and trust.
• Others mentioned: Jeff Childers (Coffee & COVID) who publicized Warner’s diagnosis; John Davidson (BrokenTruth.TV); Florida case involving Ken Lee and CPS action against a mother of a cystic fibrosis patient; Dr. Kory and physicians from an Independent Medical Association/Alliance who weighed in on Warner’s case.

Purpose and framing

• Warner initiated the discussion to explain how the advocacy service supported him during a life-threatening, fast-moving cancer crisis and to inform others about the breadth of services available—especially when conventional systems are slow, fragmented, or unresponsive.

Overview of the advocacy service model

Scope, team, and origins

• Virtual patient advocacy serving clients in all 50 U.S. states and 30+ countries; team of 30+ advocates with varied clinical/administrative specialties (nursing, pharmacy/pharmaceuticals, insurance, pediatrics/neonatal, etc.).
• Founded March 2020 (pre-lockdowns/mandates), built around practical navigation of complex care—likened to having a trusted “mechanic under the hood” who understands how the system actually works.
• Communication model: clients can call/text their assigned advocate for real-time guidance.

Core philosophy

• Integrative, individualized care plans that blend conventional medicine with evidence-informed alternatives (dietary measures, nutraceuticals/supplements) when appropriate.
• Explicit focus on “all options,” including how to safely combine, dose, and schedule adjuncts with standard therapies; strong emphasis on avoiding harmful interactions and on monitoring.
• “Freedom-fighting” advocacy orientation: helping clients access care and options when institutional policies, insurance, or administrative barriers impede timely or personalized care.

Acceleration and navigation of care

• Common system failures cited: long waits to see physicians, lack of a clear plan, call-center bottlenecks, paperwork/insurance denials, and delayed diagnostics.
• Advocates expedite: scheduling (e.g., MRI/CT), insurance approvals via accurate orders and medical-necessity framing, price negotiation, and escalation when delays are dangerous.
• Insurance guidance: reviewing existing policies; advising on mid-year policy changes when feasible; educating on health-sharing, catastrophic/accident coverage, and how to avoid surprise billing/denials.

Oncology specialization and safety oversight

• Dr. Orlando Silva’s role: integrative oncology oversight, including perspectives on vitamin D, ivermectin, fenbendazole/mebendazole, and how these may interact with chemotherapy; emphasis on correct dosing and scheduling rather than ad hoc use.
• Monitoring approach: routine labs (e.g., tumor markers, CBC, vitamin D), selective imaging (balancing radiation exposure with clinical necessity), and organ-function checks to ensure therapies—conventional and adjunct—remain safe and effective; rapid protocol pivots if toxicity or resistance emerges.

Warner Mendenhall’s case experience

Diagnosis and initial condition

• Diagnosed early December with stage 4C cancer involving metastasis; described the situation as dire. Hospital teams pulled him “back from the brink,” and he is now on a difficult but informed path to healing.

Care plan and support received

• Hybrid therapy: hospital-based chemotherapy (University Hospitals) plus supervised adjunct nutraceuticals.
• Advocacy impact:
  • Accelerated scheduling for urgently needed imaging and appointments when time was critical.
  • Rapid initiation of adjunct support: a care package delivered Dec 26 to start nutraceuticals quickly.
  • Physician oversight: licensed doctors within/through the service advised on what to take, when, and how to avoid interactions with chemotherapy; warned that widely circulated protocols can be contradictory without individualized supervision.
  • Practical coordination: his advocate (Kim) created schedules, dosing lists, and kept him on track during periods of pain/fog, when executive function and focus were limited.
  • Interpretation: explained complex lab results, acronyms, highs/lows, and what specific abnormalities meant in context; served as a sounding board even though Warner is experienced with medical records via malpractice work.
  • Insurance: access to an insurance advisor to assess coverage, identify mid-year switching options, and align policy with evolving needs.

Emphasis on individualized therapy and safety

• Warner repeatedly stressed that adjuncts must be personalized and monitored with ongoing testing (for liver/kidney tolerance and other organ safety). What works for one patient could be dangerous for another; fast changes are necessary if toxicity appears.

Gratitude and public support

• Acknowledged widespread support after Jeff Childers publicized his diagnosis; noted practical needs of maintaining a small law practice during treatment and expressed deep thanks to donors.

Nonprofit arm: Grateful Giving (501(c)(3))

Purpose and mechanics

• Launched 2022 to fund advocacy time for clients in financial hardship; donations routed directly to pay advocates’ hours for specific cases (not general overhead).
• Donation access: via the top of the service’s website (guest referenced a heart icon/button on the homepage).

Illustrative cases funded

• ICU intubation-avoidance case (Vera and Jim McKenna; story published with permission): patient in ICU for six weeks on BiPAP; team intervened when intubation was the only option offered and the family faced financial hardship.
• Pediatric “bloodless” heart surgery in California during COVID for an infant with two cardiac defects; preoperative optimization reduced transfusion need; contingency plans were in place.

Allocation and expectations

• Funds prioritized for engaged patients/families (not an entitlement model); repeat themes: helping vaccine-injured return to work, supporting single moms, veterans, and seniors.
• Advocate matching model (“like dating”): clients are paired with an advocate who best fits the clinical/administrative needs of the case.

Beyond cancer: breadth of advocacy scenarios

High-volume oncology inquiries

• Approximately 70% of current inbound contacts relate to cancer, across ages from toddlers to seniors; frequent questions on whether/when to biopsy, fear of seeing doctors, and uncertainty about the first steps.

Other common scenarios

• Vaccine injuries: navigation, workup strategies, integrating supplements and pharmaceuticals cautiously.
• Senior care: addressing unsafe conditions in facilities; transitions to safer environments to avoid recurrent hospitalizations.
• Proactive home preparedness: “cabinet planning” for people who wish to avoid hospitals, including what to keep on hand and how to use it appropriately.
• Medication/supplement management: many clients have cabinets full of supplements but lack a plan; advocates organize rational regimens and supervise tapering/transitioning from pharmaceuticals when appropriate and safe.
• Pediatrics: advising parents who face pressure to follow rigid schedules; strategies to avoid being labeled “noncompliant” in EHRs and to preserve informed choice.

System gaps and the case for advocacy

• Delay of care as a critical harm: weeks without a plan, absence of physician contact, and sitting-duck scenarios are common and dangerous.
• Administrative obstacles: improper orders, insurance denials, and call-center barriers impede care; skilled advocates fix orders, establish medical necessity, and expedite testing.
• Institutional constraints on clinicians: some physicians feel constrained by policies/procedures; advocates help clients pursue necessary diagnostics and care paths outside rigid frameworks when warranted.
• Continuous monitoring mindset: labs and imaging at reasonable intervals to verify efficacy/toxicity, adapt to potential treatment resistance, and maintain organ safety.

Legal, social, and media context

• BrokenTruth.TV: A follow-up video segment is planned for Monday; a previously scheduled session was postponed due to a high-profile Florida case.
• Florida CPS/medical freedom case: A mother of a cystic fibrosis patient faced custody risk due to healthcare decisions; hearing was continued amid heightened attention (reportedly reaching the governor’s office and legislators). Highlights broader risks when courts or agencies treat dissent from standard recommendations as neglect.
• Judicial dynamics: anecdotes of judges ordering vaccines and defaulting to CDC schedules; warning about long-term consequences of “noncompliant” labels in EHRs, which are notoriously hard to amend.
• Call for unity: Priscilla urged collaboration among attorneys, physicians, nurses, and advocates despite differing protocols; goal is to align on safe, individualized pathways for patients.

Audience intervention: Shelly’s perspective

• Empathy and support: Offered prayers and solidarity to Warner, acknowledging the sudden life disruption serious illness causes.
• Skepticism and caution:
  • Reported being vaccine-injured and on cancer protocols; said many U.S. clinicians won’t perform needed testing; argued that overseas testing (Japan, Germany, Mexico) is often required to find “real answers.”
  • Warned that supplements/protocols (e.g., fenbendazole) can be ineffective without correct testing/indications; shared that after 1.5 years on fenbendazole she has worsened, though some overseas treatments provided partial benefit.
  • Asserted there is no “cure” for persistent spike-related issues and that certain overseas interventions are maintenance, not cures; cited high costs (Japan ~$25–45k; Germany reportedly cheaper).
  • Expressed distrust of parts of the system and difficulties achieving unity due to misinformation or lack of transparency; referenced liability shields (PREP Act context) as a structural barrier to redress.
• Exchange with Warner: He acknowledged the need for continued testing and mentioned work in Japan (referenced researcher), while Shelly emphasized that, in her view, more testing isn’t the solution and that marketed “cures” are misleading.

Notable clinical/process points emphasized

• Individualization above all: Protocols must be customized and overseen by clinicians who can reconcile conventional and alternative approaches.
• Dosing and scheduling matter: Especially for agents like ivermectin and fenbendazole/mebendazole; improper self-directed regimens are common and risky.
• Safety monitoring: Regular labs (e.g., CBC, vitamin D, tumor markers), periodic imaging, and organ-function tracking are essential to detect toxicity and guide changes.
• Timeliness: Rapid initiation of supportive measures and expedited diagnostics can be lifesaving in advanced disease.
• Insurance leverage: Proper documentation (diagnoses, orders, medical necessity) can unlock approvals and lower denial risk; midyear policy changes may be possible when circumstances change.

Outcomes and testimonials cited

• Warner: Stabilized from a dire presentation; now tolerating his hybrid regimen with acceptable organ function to date, supported by frequent testing and feedback loops.
• Advocacy case examples:
  • Stage 4 patient reported to be “in remission” after an integrative plan (testimonial on the service’s site).
  • Pediatric bloodless cardiac surgery completed successfully with preoperative optimization and contingency planning.
  • ICU case where intubation was the only option offered; advocacy mobilized alternative planning amid financial hardship.

Practical details and next steps mentioned

• Donations: Grateful Giving (501(c)(3))—donation link via the heart icon at the top of the service’s website; funds pay directly for advocate time for clients in financial hardship.
• Follow-ups: A video conversation is planned for Monday on BrokenTruth.TV to continue the discussion (likely less interactive).
• Social channels: The advocacy service is on X (logo includes a heart with a puzzle piece), Facebook, Instagram, and Telegram.
• Warner’s support: A GiveSendGo exists to support Warner’s practice and personal treatment needs; he expressed deep gratitude for public contributions.

Key takeaways

• Advanced illness demands a cohesive, time-sensitive, and individualized plan integrating conventional and adjunctive options.
• The advocacy model described addresses common system failures—delays, communication breakdowns, and insurance barriers—by providing hands-on navigation and clinical coordination.
• Safety and efficacy in integrative oncology hinge on expert oversight, correct dosing/scheduling, and continuous lab/imaging monitoring to protect organ function and adapt to resistance.
• Financial barriers are addressed via a nonprofit arm that funds advocate hours directly for engaged patients in hardship.
• Broader medical freedom concerns—especially for pediatrics and vaccine-injured populations—require legal, clinical, and advocacy collaboration to safeguard informed choice and prevent punitive labeling in records.
• Lived experiences differ: while some patients report strong progress on supervised integrative plans, others (like Shelly) caution that certain protocols may not help without appropriate diagnostics and that some interventions are costly and palliative/maintenance rather than curative. Continuous critical evaluation and trustworthy guidance are essential.